Clinical Trial Update: Gypenosides Treatment for Optic Neuritis [Phase 2]

View source ↗

Summary

Phase 2 trial of Gypenosides for optic neuritis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Optic Neuritis

Drugs mentioned

• Gypenosides (gypenosides)

Snippet

Sponsor: First Affiliated Hospital of Guangxi Medical University | Conditions: Optic Neuritis | Phase 2 | Status: TERMINATED